Navigation Links
Generex Provides Corporate Update
Date:8/2/2011

WORCESTER, Mass. and TORONTO, Aug. 2, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) (www.generex.com) is pleased to provide its shareholders with a corporate update of developments that have been achieved since the appointment of Mark Fletcher as President & Chief Executive Officer on September 29, 2010.

"Since my appointment as President & Chief Executive Officer of Generex, I have made it a priority to proactively communicate significant catalysts to the investment community and to our stockholders with the objective achieving credibility, respect and, most importantly, shareholder value," said Mark Fletcher.  "Generex is at a pivotal point in its growth cycle as a biotechnology company, and we will continue to advance with our strategic development plan in order to unlock the Company's true value and pave the way for future innovations in both the diabetes and oncology spaces."

The developments that have been achieved since the Company's reorganization are as follows:

  • Focused on Delivering on its Strategic Development Plan.  On March 30, 2011, the Company unveiled its strategic development plan seeking to (a) obtain shareholder approval to implement a reverse stock split in conjunction with a national exchange listing, and (b) to spin off its wholly-owned subsidiary Antigen Express, Inc. (www.antigenexpress.com) as a separate DTC-eligible SEC registered company, which will include the issuance of one or more dividends of Antigen Express stock to Generex stockholders.  On June 8, 2011, at the Company's annual meeting of stockholders, Generex stockholders approved the proposal to amend the Company's Restated Certificate of Incorporation to effect a reverse stock split.

  • Updated the Generex Oral-lyn™ Clin
    '/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ("Sony") ... Spectral Analyzer (SP6800).  Sony will be exhibiting and taking ... be held at the San Diego ... , from May 20 - 22.  ... system, incorporating commercial audio-visual technologies into new and novel ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group ... for their competitive landscape map for the Chronic ... over 90 international companies with drugs and devices ... CKD and its sequelae. (Logo:  ... , hypertension - renal denervation ...
(Date:5/17/2013)... Puerto Rico , May 17, 2013  Serving a ... Puerto Rico , Caribbean Imaging and Radiation Therapy ... its radiation therapy capabilities with the acquisition of an Elekta ... . Versa HD offers clinicians the versatility to deliver ... the body, while also enabling treatment of highly complex cancers ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... the FDA announced,approval for the first clinical trials on ... Christian Drapeau says the experts may not be,telling the ... less,risk. , "While the FDA ... the shackles of politics," said Drapeau. "The expert commentary ...
... of MSI-1436 in DIO Rats Highlighted -PLYMOUTH MEETING, ... Corporation (Nasdaq: GENR ) today announced ... (MSI-1436), Genaera,s lead drug candidate for the treatment ... Keystone Symposia: Obesity - Novel Aspects of the ...
Cached Medicine Technology:FDA Stem Cell Approval Breakthrough Laudable 2Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia 2Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia 3
(Date:5/20/2013)... May 20, 2013 Idol lash has designed ... darker and fuller eyelashes in a matter of few weeks. ... online purchase with an extra pack offer to help more ... access this offer on the Idol lash official website. , ... increase the eyelash density up to 82% in just a ...
(Date:5/20/2013)... 20, 2013 The US Drug ... of a transvaginal mesh failure, we are now calling ... we have ever seen for women, and the damages ... a potentially huge number of US women. According to ... underwent procedures in which mesh was implanted vaginally to ...
(Date:5/20/2013)... Atlanta, GA (PRWEB) May 20, 2013 ... Vision Institute published a testimonial about how one of ... for a LASIK consultation after being diagnosed with giant ... a foreign object in the eye, and for one ... lenses that caused this allergy,” says the Medical Director ...
(Date:5/20/2013)... 2013 The Mesothelioma Victims Center ... Navy Veterans who are diagnosed with mesothelioma get shortchanged ... they, or their family members turned to a local ... of the most skilled, and experienced mesothelioma lawyers in ... mesothelioma in the US never even bother to explore ...
(Date:5/20/2013)... 20, 2013 Milpitas, Los Angeles, ... leader in enterprise-class information archiving, eDiscovery and migration ... 7.0, the latest release in the MessageSolution product ... the legal discovery lifecycle. MessageSolution will exhibit at ... CA. , As the first stop of the ...
Breaking Medicine News(10 mins):Health News:Idol Lash Eyelash Growth Enhancer Now Offered Extra Pack for Limited Time Only at HealthCareSupplementz.com 2Health News:US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With Erosion To Call Them For The Names And Contacts Of The Best Women Attorneys 2Health News:Atlanta LASIK Practice Publishes a Patient’s Testimonial About Allergy to Contact Lenses 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4
... The advantage that children get from living in two-parent families ... fact that their parents are married. A new study ... in stable single-parent homes generally do as well as those ... problems. "Many of the studies that show an advantage ...
... , , , ... antimicrobial skin care company, announced today that an independent testing laboratory ... H1N1 flu virus. The test results show HandClens is 99.99% ... submit these results to the FDA as an addendum to its ...
... , , NEW YORK, Aug. ... according to The Conference Board Help-Wanted OnLine Data Series (HWOL)(TM) ... with many of the largest States now showing stable trends following about ... data, there are now three States (New York, Maryland and Virginia) where ...
... , , GREENWICH, Conn., Aug. 31 ... system for treatment of bowel incontinence. Secca Therapy is ... that affects tens of millions of Americans, both young and ... of the anal canal - tightening the muscles, producing better ...
... , , , ... WTW ) announced today the start of the second annual Lose ... obesity and hunger. Between August 30th and October 17th, as Weight ... to $1 million to two hunger fighting organizations - Share Our Strength ...
... Italy, August 31 Health Robotics today announced,that ... agreed to,immediately install its flagship CytoCare Robot during ... an exclusive 3-year distribution,licensing, and support contract with ... and Pinnaclemed desire to safely, accurately, and,cost-effectively automate ...
Cached Medicine News:Health News:Family stability may be more crucial than 2 parents for child success 2Health News:Family stability may be more crucial than 2 parents for child success 3Health News:Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus 2Health News:Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus 3Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 2Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 3Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 4Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 5Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 6Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 7Health News:Secca(R) Therapy - An Effective and Minimally Invasive Option for Treating Bowel Incontinence - Launched in the US 2Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 2Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 3Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 4Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 5Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 2Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 3Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 4
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 11.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Medicine Products: